Renal Cancer
Phase I LITESPARK-001 study of belzutifan for advanced solid tumors: Extended 41-month follow-up in the clear cell renal cell carcinoma cohort.
November 29, 2023
Sodium Levels and Outcomes in Patients With Metastatic Renal Cell Carcinoma Receiving Nivolumab.
November 28, 2023
Nucleotide excision repair deficiency is a targetable therapeutic vulnerability in clear cell renal cell carcinoma.
November 27, 2023
BR55 Ultrasound Molecular Imaging of Clear Cell Renal Cell Carcinoma Reflects Tumor Vascular Expression of VEGFR-2 in a Patient-Derived Xenograft Model.
November 27, 2023
Genes associated with inflammation for prognosis prediction for clear cell renal cell carcinoma: a multi-database analysis.
November 24, 2023
Selection of M7G-related lncRNAs in kidney renal clear cell carcinoma and their putative diagnostic and prognostic role.
November 24, 2023
A phase II trial of nivolumab followed by ipilimumab and nivolumab in advanced non-clear-cell renal cell carcinoma.
November 22, 2023
Long-Term Follow-Up in Patients Undergoing Renal Mass Biopsy: Seeding is not Anecdotal.
November 22, 2023
Perceptions of DNA Sequencing Among Patients with Cancer from Diverse Ancestries - Expert Commentary
November 21, 2023
Prognostic Significance of Radiographic Lymph Node Invasion in Contemporary Metastatic Renal Cell Carcinoma Patients.
November 21, 2023
Benefits of Routine Screening for Renal Cell Carcinoma of Native Kidney in Renal Transplant Recipients.
November 20, 2023